A peer-reviewed study published in the research journal PLOS ONE demonstrates that MDMA-assisted psychotherapy is cost-effective in the treatment of posttraumatic stress disorder (PTSD). It is estimated that public healthcare payers or private insurers making MDMA-assisted psychotherapy available to 1,000 patients would reduce general and mental health care costs by $103.2 million over 30 years…. Read more »
